Recurrent Pericardial Effusion in a Patient With Delayed Progression of Melanoma Treated With Immune Checkpoint Inhibitors

Two commonly used immune checkpoint inhibitors (ICIs) utilized in the treatment of metastatic melanoma are nivolumab, a programmed death (PD-1) checkpoint inhibitor, and ipilimumab, a cytotoxic T-lymphocyte antigen (CTLA-4) checkpoint inhibitor. However, due to the activation of the immune system, I...

Descripción completa

Detalles Bibliográficos
Autores principales: Valencia, Elsie A, Anumolu, Natalie, Jha, Pinky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676191/
https://www.ncbi.nlm.nih.gov/pubmed/38021498
http://dx.doi.org/10.7759/cureus.47727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676191/
https://www.ncbi.nlm.nih.gov/pubmed/38021498
http://dx.doi.org/10.7759/cureus.47727

Ejemplares similares